4 citations
,
May 2021 in “medRxiv (Cold Spring Harbor Laboratory)” This review found that common post-acute COVID-19 symptoms include fatigue, dyspnea, insomnia, and anxiety, indicating they can persist beyond 60 days after initial infection.
6 citations
,
December 2023 in “Lancet. Infectious diseases/The Lancet. Infectious diseases” This study found that treatment with the synbiotic SIM01 significantly alleviated multiple symptoms of post-acute COVID-19 syndrome compared to placebo, suggesting potential management benefits through gut microbiome modulation.
July 2023 in “Zenodo (CERN European Organization for Nuclear Research)” In this review, researchers reported that post-COVID-19 syndrome may lead to significant sequelae like hair loss, potentially due to acute telogen effluvium, affecting around 20% of patients and impacting their quality of life, though specific studies on this relationship are lacking.
32 citations
,
June 2021 in “bioRxiv (Cold Spring Harbor Laboratory)” This systematic review found that long COVID symptoms, particularly fatigue, sleep disorder, and dyspnoea, were similarly prevalent in ongoing symptomatic COVID-19 and post-COVID-19 syndrome, but psychological issues and poor quality of life were more common in the latter.
1 citations
,
July 2025 in “Frontiers in Pharmacology” This review summarizes how foods with both medicinal and nutritional properties are being examined for their potential role in addressing post-acute COVID-19 syndrome, but it reports no new clinical results.